Prevalence of Dry Eye Disease in Patients Diagnosed With Rheumatoid Arthritis

This study will evaluate the prevalence of dry eye disease in patients diagnosed with rheumatoid arthritis. No treatment is administered in this study.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dry Eye Syndromes Arthritis Arthritis, Rheumatoid Autoimmune Diseases Connective Tissue Diseases Eye Diseases Immune System Diseases Joint Diseases Lacrimal Apparatus Diseases Musculoskeletal Diseases Rheumatic Diseases Rheumatoid Arthritis Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

About this study

We investigated the prevalence of dry eye disease in patients diagnosed with rheumatoid arthritis by information sheets and direct recruitment of patients of potential study participants diagnosed with rheumatoid arthritis. Subjective assessment for dry eye disease was performed using Ocular Surface Disease Index (OSDI) questionnaire. The following objective tests of dry eye disease were employed: tear osmolarity (TO), tear break-up time (TBUT), corneal fluorescein staining score and conjunctival lissamine green staining scores using the National Eye Institute-recommended grading system, and Schirmer without anesthetic. The Dry Eye Severity Grading Scheme highlighted by the Dry Eye WorkShop was adapted to quantify dry eye disease severity level.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diagnosed with rheumatoid arthritis
18 years old or older
Speaks and understands English and/or Spanish

Exclusion criteria

Unable to provide consent

Treatment and study plan

No intervention

Other

Primary outcomes

Number of Participants Diagnosed With Rheumatoid Arthritis Also Found to Have Dry Eye Disease

Time frame: 1 day

Sponsors and collaborators

Lead sponsor

Western University of Health Sciences

Other

Collaborators

Allergan

Registry information

Important dates

Study start: 2012
Primary completion: 2014
Study completion: 2014
First posted: Sep 30, 2014
Registry last updated: Feb 3, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed